180 related articles for article (PubMed ID: 25331151)
1. Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Buchanan R; Stoesser N; Crook D; Bowler IC
BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25331151
[TBL] [Abstract][Full Text] [Related]
2. Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms.
Totsika M; Beatson SA; Sarkar S; Phan MD; Petty NK; Bachmann N; Szubert M; Sidjabat HE; Paterson DL; Upton M; Schembri MA
PLoS One; 2011; 6(10):e26578. PubMed ID: 22053197
[TBL] [Abstract][Full Text] [Related]
3. Comparative Genomics of
Ranjan A; Shaik S; Nandanwar N; Hussain A; Tiwari SK; Semmler T; Jadhav S; Wieler LH; Alam M; Colwell RR; Ahmed N
mBio; 2017 Aug; 8(4):. PubMed ID: 28811343
[No Abstract] [Full Text] [Related]
4. Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-
Kanamori H; Parobek CM; Juliano JJ; Johnson JR; Johnston BD; Johnson TJ; Weber DJ; Rutala WA; Anderson DJ
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584139
[No Abstract] [Full Text] [Related]
5. Whole genome sequencing reveals high clonal diversity of
Sonda T; Kumburu H; van Zwetselaar M; Alifrangis M; Mmbaga BT; Aarestrup FM; Kibiki G; Lund O
Antimicrob Resist Infect Control; 2018; 7():72. PubMed ID: 29977533
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
[TBL] [Abstract][Full Text] [Related]
7. Fatal Escherichia coli skin and soft tissue infections in liver transplant recipients: report of three cases.
Janny S; Bert F; Dondero F; Chanoine MH; Belghiti J; Mantz J; Paugam-Burtz C
Transpl Infect Dis; 2013 Apr; 15(2):E49-53. PubMed ID: 23278949
[TBL] [Abstract][Full Text] [Related]
8. Widespread high-risk clones of multidrug-resistant extended-spectrum β-lactamase-producing Escherichia coli B2-ST131 and F-ST648 in public aquatic environments.
Furlan JPR; Savazzi EA; Stehling EG
Int J Antimicrob Agents; 2020 Jul; 56(1):106040. PubMed ID: 32479889
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.
Tello M; Ocejo M; Oporto B; Hurtado A
Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32471914
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model.
DeRyke CA; Banevicius MA; Fan HW; Nicolau DP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1481-6. PubMed ID: 17283197
[TBL] [Abstract][Full Text] [Related]
11. Cross-border emergence of clonal lineages of ST38 Escherichia coli producing the OXA-48-like carbapenemase OXA-244 in Germany and Switzerland.
Falgenhauer L; Nordmann P; Imirzalioglu C; Yao Y; Falgenhauer J; Hauri AM; Heinmüller P; Chakraborty T
Int J Antimicrob Agents; 2020 Dec; 56(6):106157. PubMed ID: 32919009
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic trapping by plasmid-encoded CMY-2 β-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli.
Goessens WH; van der Bij AK; van Boxtel R; Pitout JD; van Ulsen P; Melles DC; Tommassen J
Antimicrob Agents Chemother; 2013 Aug; 57(8):3941-9. PubMed ID: 23733461
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomics of an IncA/C multidrug resistance plasmid from Escherichia coli and Klebsiella isolates from intensive care unit patients and the utility of whole-genome sequencing in health care settings.
Hazen TH; Zhao L; Boutin MA; Stancil A; Robinson G; Harris AD; Rasko DA; Johnson JK
Antimicrob Agents Chemother; 2014 Aug; 58(8):4814-25. PubMed ID: 24914121
[TBL] [Abstract][Full Text] [Related]
14. Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic
Shaik S; Ranjan A; Tiwari SK; Hussain A; Nandanwar N; Kumar N; Jadhav S; Semmler T; Baddam R; Islam MA; Alam M; Wieler LH; Watanabe H; Ahmed N
mBio; 2017 Oct; 8(5):. PubMed ID: 29066550
[No Abstract] [Full Text] [Related]
15. High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique.
Estaleva CEL; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Simonsen GS; Haldorsen B; Essack SY; Sundsfjord A
BMC Infect Dis; 2021 Jan; 21(1):16. PubMed ID: 33407206
[TBL] [Abstract][Full Text] [Related]
16. First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.
Namaei MH; Yousefi M; Ziaee M; Salehabadi A; Ghannadkafi M; Amini E; Askari P
Microb Drug Resist; 2017 Oct; 23(7):879-884. PubMed ID: 28437226
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of extended-spectrum β-lactamase/plasmid AmpC-β-lactamase-producing Escherichia coli isolates from long-term recurrent bloodstream infections.
Roer L; Hansen F; Hasman H; Hammerum AM; Cavaco LM
Int J Antimicrob Agents; 2020 Jul; 56(1):106041. PubMed ID: 32479890
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH).
Lim CL; Lee W; Lee AL; Liew LT; Nah SC; Wan CN; Chlebicki MP; Kwa AL
BMC Infect Dis; 2013 Nov; 13():523. PubMed ID: 24195651
[TBL] [Abstract][Full Text] [Related]
20. Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen.
Lee CH; Su LH; Lin WC; Tang YF; Liu JW
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e183-6. PubMed ID: 19800278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
